During the past decade, Endocrine and Metabolic Consultants conducted 15 clinical trials. In the 10-year time frame, 15 clinical trials started and 8 clinical trials were completed, i.e. on average, 53.3% percent of trials that started reached the finish line to date. In the past 5 years, 13 clinical trials started and 8 clinical trials were completed. i.e. 61.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Endocrine and Metabolic Consultants" #1 sponsor was "Eli Lilly and Company" with 11 trials, followed by "Boehringer Ingelheim" with 1 trials sponsored, "Eisai Inc." with 1 trials sponsored, "Gan and Lee Pharmaceuticals, USA" with 1 trials sponsored and "Inversago Pharma Inc." with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Endocrine and Metabolic Consultants" #1 collaborator was "Eli Lilly and Company" with 1 trials as a collaborator, "Thrombolysis In Myocardial Infarction (TIMI) Academic Research Organization" with 1 trials as a collaborator and "Worldwide Clinical Trials" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Endocrine and Metabolic Consultants" are "Type 2 Diabetes" (5 trials), "Type 2 Diabetes Mellitus" (4 trials), "Type 1 Diabetes Mellitus" (3 trials), "Diabetes" (2 trials) and "Cardiovascular Disease" (1 trials). Many other conditions were trialed in "Endocrine and Metabolic Consultants" in a lesser frequency.

Most popular intervention types in "Endocrine and Metabolic Consultants" are "Drug" (14 trials), "Biological" (2 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Insulin Degludec" (7 trials), "Insulin Efsitora Alfa" (3 trials), "LY3209590" (3 trials), "Tirzepatide" (3 trials) and "Placebo" (2 trials). Other intervention names were less common.

The vast majority of trials in "Endocrine and Metabolic Consultants" are 17 trials for "All" genders.

Currently, there are NaN active trials in "Endocrine and Metabolic Consultants". undefined are not yet recruiting, 2 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 9 completed trials in Endocrine and Metabolic Consultants, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Endocrine and Metabolic Consultants, 0 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 11 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 1 trials that are defined as “Not Applicable".